VSports app下载 - Browse by Glasgow Author

2025

V体育ios版 - Herbert, Katharine J. ORCID: https://orcid. org/0000-0001-9437-0253, "V体育平台登录" Upstill-Goddard, Rosie, Dreyer, Stephan B. , Rebus, Selma, Pilarsky, Christian, Debabrata, Mukhopadhyay, Lord, Christopher J VSports. , Biankin, Andrew V. ORCID: https://orcid. org/0000-0002-0362-5597, Froeling, Fieke E. M. ORCID: https://orcid. org/0000-0002-8653-8164 and Chang, David K. ORCID: https://orcid. org/0000-0002-4821-3078 (2025) Sequential ATR and PARP inhibition overcomes acquired DNA damaging agent resistance in pancreatic ductal adenocarcinoma. British Journal of Cancer, 133(3), pp. 381-393. (doi: 10. 1038/s41416-025-03051-z) (PMID:40442403) .

Dreyer, Stephan B. (VSports注册入口), Beer, Philip, Hingorani, Sunil R. and Biankin, Andrew (VSports app下载) ORCID: https://orcid.org/0000-0002-0362-5597 (2025) Improving outcomes of patients with pancreatic cancer. Nature Reviews Clinical Oncology, 22(6), pp. 439-456. (doi: 10.1038/s41571-025-01019-9) (PMID:40329051)

2024 (VSports在线直播)

Casolino, R V体育官网. et al. (2024) Interpreting and integrating genomic tests results in clinical cancer care: Overview and practical guidance. CA: A Cancer Journal for Clinicians, 74(3), pp. 264-285. (doi: 10. 3322/caac. 21825) (PMID:38174605) .

Cooke, S. F VSports手机版. et al. (2024) Disruption of the pro-oncogenic c-RAF–PDE8A complex represents a differentiated approach to treating KRAS–c-RAF dependent PDAC. Scientific Reports, 14, 8998. (doi: 10. 1038/s41598-024-59451-3) (PMID:38637546) (PMCID:PMC11026450) .

Agostini, A. et al. (2024) Identification of spatially-resolved markers of malignant transformation in Intraductal Papillary Mucinous Neoplasms V体育安卓版. Nature Communications, 15(1), 2764. (doi: 10. 1038/s41467-024-46994-2) (PMID:38553466) (PMCID:PMC10980816) .

Zhang, S. et al V体育ios版. (2024) Roflumilast inhibits tumor growth and migration in STK11/LKB1 deficient pancreatic cancer. Cell Death Discovery, 10, 124. (doi: 10. 1038/s41420-024-01890-y) (PMID:38461159) (PMCID:PMC10924943) .

Dreyer, Stephan (V体育官网), Bryce, Adam ORCID: https://orcid.org/0000-0003-0253-9723, Australian Pancreatic Cancer Genome Initiative, Biankin, Andrew (VSports最新版本) ORCID: https://orcid.org/0000-0002-0362-5597, Jamieson, Nigel (VSports) ORCID: https://orcid.org/0000-0002-9552-4725 and Chang, David ORCID: https://orcid.org/0000-0002-4821-3078 (2024) The clinical and molecular landscape of early onset pancreatic cancer. 42nd Congress of the European Society of Surgical Oncology, Florence, Italy, 25-27 Oct 2023. (doi: 10.1016/j.ejso.2023.107348)

Canel, M. et al. (2024) FAK suppresses antigen processing and presentation to promote immune evasion in pancreatic cancer. Gut, 73(1), pp V体育平台登录. 131-155. (doi: 10. 1136/gutjnl-2022-327927) (PMID:36977556) (PMCID:PMC10715489) .

2023

Golan, Talia, Casolino, Raffaella, Biankin, Andrew V. (V体育2025版) ORCID: https://orcid. org/0000-0002-0362-5597, "VSports最新版本" Hammel, Pascal, Whitaker, Kristen D VSports注册入口. , Hall, Michael J. and Riegert-Johnson, Douglas L. (2023) Germline BRCA testing in pancreatic cancer: improving awareness, timing, turnaround, and uptake. Therapeutic Advances in Medical Oncology, 15, p. 17588359231189127. (doi: 10. 1177/17588359231189127) (PMID:37720496) (PMCID:PMC10504836) .

Wood, C V体育官网入口. S. et al. (2023) Spatially resolved transcriptomics deconvolutes prognostic histological subgroups in patients with colorectal cancer and synchronous liver metastases. Cancer Research, 83(8), pp. 1329-1344. (doi: 10. 1158/0008-5472. CAN-22-2794) (PMID:37057593) (PMCID:PMC10102851) .

Tempero, M. A. et al. (2023) Adjuvant nab-paclitaxel + gemcitabine in resected pancreatic ductal adenocarcinoma: results from a randomized, open-label, phase III trial VSports在线直播. Journal of Clinical Oncology, 41(11), pp. 2007-2019. (doi: 10. 1200/JCO. 22. 01134) (PMID:36521097) (PMCID:PMC10082313) .

Paiella, S. et al. (2023) A systematic review and meta-analysis of germline BRCA mutations in pancreatic cancer patients identifies global and racial disparities in access to genetic testing. ESMO Open, 8(2), 100881. (doi: 10. 1016/j. esmoop V体育2025版. 2023. 100881) (PMID:36822114) (PMCID:PMC10163165) .

Casolino, R. et al. (2023) Accelerating cancer omics and precision oncology in health care and research: a Lancet Oncology Commission. Lancet Oncology, 24(2), pp. 123-125. (doi: 10.1016/S1470-2045(23)00007-4) (PMID:36725142)

Dreyer, S. B. et al. (2023) The impact of molecular subtyping on pathological staging of pancreatic cancer. Annals of Surgery, 277(2), e396-e405. (doi: 10.1097/SLA.0000000000005050) (PMID:36745763) (PMCID:PMC9831035)

2022

Ali, A. et al. (2022) Prognostic implications of microRNA-21 overexpression in pancreatic ductal adenocarcinoma: an international multicenter study of 686 patients. American Journal of Cancer Research, 12(12), pp. 5668-5683. (PMID:36628279) (PMCID:PMC9827095)

Ho, G.-Y. et al. (2022) Epithelial-to-mesenchymal transition supports ovarian carcinosarcoma tumorigenesis and confers sensitivity to microtubule-targeting with eribulin. Cancer Research, 82(23), pp. 4457-4473. (doi: 10.1158/0008-5472.can-21-4012) (PMID:36206301) (PMCID:PMC9716257)

Moser, R. et al. (2022) Pharmacological targeting of TFIIH suppresses KRAS mutant pancreatic ductal adenocarcinoma and synergizes with TRAIL. Cancer Research, 82(18), pp. 3375-3393. (doi: 10.1158/0008-5472.CAN-21-4222) (PMID:35819261)

"VSports最新版本" Beer, Philip A. and Biankin, Andrew V. ORCID: https://orcid.org/0000-0002-0362-5597 (2022) Bridging the implementation gap: delivering complex genomic analysis for routine cancer care. Annals of Oncology, 33(9), pp. 857-859. (doi: 10.1016/j.annonc.2022.06.015) (PMID:35931317)

Zeng, S. et al. (2022) CDK7 inhibition augments response to multidrug chemotherapy in pancreatic cancer. Journal of Experimental and Clinical Cancer Research, 41, 241. (doi: 10.1186/s13046-022-02443-w) (PMID:35945614) (PMCID:PMC9364549)

Horgan, D. et al. (2022) Meeting the need for a discussion of unmet medical need. Healthcare, 10(8), 1578. (doi: 10.3390/healthcare10081578) (PMID:36011235) (PMCID:PMC9408346)

VSports - Casolino, Raffaella, Corbo, Vincenzo, Beer, Philip, Hwang, Chang-Il, Paiella, Salvatore, Silvestri, Valentina (V体育2025版), VSports注册入口 - Ottini, Laura and Biankin, Andrew V. ORCID: https://orcid.org/0000-0002-0362-5597 (2022) Germline aberrations in pancreatic cancer: implications for clinical care. Cancers, 14(13), 3239. (doi: 10.3390/cancers14133239) (PMID:35805011) (PMCID:PMC9265115)

Patel, M. et al. (2022) Spatial expression of IKK-alpha is associated with a differential mutational landscape and survival in primary colorectal cancer. British Journal of Cancer, 126(12), pp. 1704-1714. (doi: 10.1038/s41416-022-01729-2) (PMID:35173303) (PMCID:PMC9174220)

Dreyer, Stephan B., Upstill-Goddard, Rosie, VSports最新版本 - Legrini, Assya ORCID: https://orcid.org/0000-0001-5377-3048, Biankin, Andrew V. ORCID: https://orcid.org/0000-0002-0362-5597, Jamieson, Nigel B. ORCID: https://orcid.org/0000-0002-9552-4725 and Chang, David K. ORCID: https://orcid.org/0000-0002-4821-3078 (2022) Genomic and molecular analyses identify molecular subtypes of pancreatic cancer recurrence. Gastroenterology, 162(1), 320-324.e4. (doi: 10.1053/j.gastro.2021.09.022) (PMID:34534536) (PMCID:PMC8721486)

Dreyer, S., Upstill-Goddard, R., "VSports手机版" Legrini, A. ORCID: https://orcid.org/0000-0001-5377-3048, Biankin, A. ORCID: https://orcid.org/0000-0002-0362-5597, Jamieson, N. ORCID: https://orcid.org/0000-0002-9552-4725 and Chang, D. ORCID: https://orcid.org/0000-0002-4821-3078 (2022) Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence. 15th World Congress of the International Hepato-Pancreato-Biliary Association, New York, USA, 30 Mar - 02 Apr 2022. S44-S45. (doi: 10.1016/j.hpb.2022.05.086)

2021

Carotenuto, P. et al. (2021) Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage. Nature Communications, 12, 6738. (doi: 10.1038/s41467-021-27099-6) (PMID:34795259) (PMCID:PMC8602334)

Murphy, K. J. et al. (2021) Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin status. Science Advances, 7(40), eabh0363. (doi: 10.1126/sciadv.abh0363) (PMID:34586840) (PMCID:PMC8480933)

Casolino, R. et al. (2021) Homologous recombination deficiency in pancreatic cancer: a systematic review and prevalence meta-analysis. Journal of Clinical Oncology, 39(23), pp. 2617-2631. (doi: 10.1200/JCO.20.03238) (PMID:34197182) (PMCID:PMC8331063)

Schwappacher, R. et al. (2021) Muscle-derived cytokines reduce growth, viability and migratory activity of pancreatic cancer cells. Cancers, 13(15), 3820. (doi: 10.3390/cancers13153820)

Ewing, A. et al. (2021) Structural variants at the BRCA1/2 loci are a common source of homologous repair deficiency in high grade serous ovarian carcinoma. Clinical Cancer Research, 27(11), pp. 3201-3214. (doi: 10.1158/1078-0432.CCR-20-4068) (PMID:33741650) (PMCID:PMC7610896)

Lakis, V. et al. (2021) DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association. Communications Biology, 4, 155. (doi: 10.1038/s42003-020-01469-0) (PMID:33536587) (PMCID:PMC7859232)

Casolino, R. et al. (2021) Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine. Annals of Oncology, 32(2), pp. 183-196. (doi: 10.1016/j.annonc.2020.11.013) (PMID:33248227) (PMCID:PMC7840891)

Griffith, Billie G.C. (V体育官网), Upstill-Goddard, Rosanna, Brunton, Hollie, Grimes, Graeme R., Biankin, Andrew ORCID: https://orcid.org/0000-0002-0362-5597, Serrels, Bryan, Byron, Adam (VSports app下载) and Frame, Margaret C. (2021) FAK regulates IL-33 expression by controlling chromatin accessibility at c-Jun motifs. Scientific Reports, 11, 229. (doi: 10.1038/s41598-020-80111-9) (PMID:33420223) (PMCID:PMC7794255)

Dreyer, S. B. et al. (2021) Targeting DNA damage response and replication stress in pancreatic cancer. Gastroenterology, 160(1), pp. 362-377. (doi: 10.1053/j.gastro.2020.09.043) (PMID:33039466) (PMCID:PMC8167930)

Froeling, Fieke E.M. ORCID: https://orcid.org/0000-0002-8653-8164, Casolino, Raffaella, Pea, Antonio, Biankin, Andrew V. ORCID: https://orcid.org/0000-0002-0362-5597 and Chang, David K. ORCID: https://orcid.org/0000-0002-4821-3078 (2021) Molecular subtyping and precision medicine for pancreatic cancer. Journal of Clinical Medicine, 10(1), 149. (doi: 10.3390/jcm10010149) (PMID:33406790) (PMCID:PMC7794969)

2020 (V体育2025版)

V体育官网入口 - Beer, Philip A., Cooke, Susanna L. ORCID: https://orcid.org/0000-0002-0955-0346, V体育2025版 - Chang, David K. ORCID: https://orcid.org/0000-0002-4821-3078 and Biankin, Andrew V. ORCID: https://orcid.org/0000-0002-0362-5597 (2020) Defining the clinical genomic landscape for real-world precision oncology. Genomics, 112(6), pp. 5324-5330. (doi: 10.1016/j.ygeno.2020.10.032) (PMID:33144218) (PMCID:PMC7758710)

Bailey, M. H. et al. (2020) Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples. Nature Communications, 11, 4748. (doi: 10.1038/s41467-020-18151-y) (PMID:32958763) (PMCID:PMC7505971)

Li, C. H. et al. (2020) Sex differences in oncogenic mutational processes. Nature Communications, 11, 4330. (doi: 10.1038/s41467-020-17359-2) (PMID:32859912) (PMCID:PMC7455744)

Dreyer, S. B. et al. (2020) Precision oncology in surgery: patient selection for operable pancreatic cancer. Annals of Surgery, 272(2), pp. 366-376. (doi: 10.1097/SLA.0000000000003143) (PMID:32675551) (PMCID:PMC7373491)

Muthalagu, N. et al. (2020) Repression of the type I interferon pathway underlies MYC & KRAS-dependent evasion of NK & B cells in pancreatic ductal adenocarcinoma. Cancer Discovery, 10(6), pp. 872-887. (doi: 10.1158/2159-8290.CD-19-0620) (PMID:32200350) (PMCID:PMC7611248)

Brunton, H. et al. (2020) HNF4A and GATA6 loss reveals therapeutically actionable subtypes in pancreatic cancer. Cell Reports, 31(6), 107625. (doi: 10.1016/j.celrep.2020.107625) (PMID:32402285)

Litchfield, K. et al. (2020) Representative sequencing: unbiased sampling of solid tumor tissue. Cell Reports, 31(5), 107550. (doi: 10.1016/j.celrep.2020.107550) (PMID:32375028)

The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium, et al. (2020) Pan-cancer analysis of whole genomes. Nature, 578(7793), pp. 82-93. (doi: 10.1038/s41586-020-1969-6) (PMID:32025007) (PMCID:PMC7025898)

Jiao, W. et al. (2020) A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns. Nature Communications, 11, 728. (doi: 10.1038/s41467-019-13825-8) (PMID:32024849) (PMCID:PMC7002586)

Dreyer, S.B., Jamieson, N.B. ORCID: https://orcid.org/0000-0002-9552-4725, Cooke, S.L. ORCID: https://orcid.org/0000-0002-0955-0346, "V体育官网入口" Valle, J.W., McKay, C.J., Biankin, A.V. ORCID: https://orcid.org/0000-0002-0362-5597 and Chang, D.K. ORCID: https://orcid.org/0000-0002-4821-3078 (2020) PRECISION-Panc: the next generation therapeutic development platform for pancreatic cancer. Clinical Oncology, 32(1), pp. 1-4. (doi: 10.1016/j.clon.2019.07.011) (PMID:31378449)

Dreyer, S.B. (VSports手机版), Jamieson, N.B. (V体育官网入口) ORCID: https://orcid.org/0000-0002-9552-4725, Morton, J.P. ORCID: https://orcid.org/0000-0001-5766-9141, Sansom, O.J. ORCID: https://orcid.org/0000-0001-9540-3010, Biankin, A.V. (VSports app下载) ORCID: https://orcid.org/0000-0002-0362-5597 and Chang, D.K. ORCID: https://orcid.org/0000-0002-4821-3078 (2020) Pancreatic cancer: from genome discovery to PRECISION-Panc. Clinical Oncology, 32(1), pp. 5-8. (doi: 10.1016/j.clon.2019.08.007) (PMID:31522943)

2019

Beer, Philip A., Cooke, Susanna L. ORCID: https://orcid.org/0000-0002-0955-0346, Chang, David K. ORCID: https://orcid.org/0000-0002-4821-3078 and Biankin, Andrew V. ORCID: https://orcid.org/0000-0002-0362-5597 (2019) Reasons to be testing: the dawn of complex molecular profiling in routine oncology practice. Annals of Oncology, 30(11), pp. 1691-1694. (doi: 10.1093/annonc/mdz392) (PMID:31665210)

Tandon, M. et al. (2019) Prolactin promotes fibrosis and pancreatic cancer progression. Cancer Research, 79(20), pp. 5316-5327. (doi: 10.1158/0008-5472.CAN-18-3064) (PMID:31395607) (PMCID:PMC6801092)

Jackstadt, R. et al. (2019) Epithelial NOTCH signaling rewires the tumor microenvironment of colorectal cancer to drive poor-prognosis subtypes and metastasis. Cancer Cell, 36(3), 319-336.e7. (doi: 10.1016/j.ccell.2019.08.003) (PMID:31526760) (PMCID:PMC6853173)

Vennin, C. et al. (2019) CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan. Nature Communications, 10, 3637. (doi: 10.1038/s41467-019-10968-6) (PMID:31406163) (PMCID:PMC6691013)

Brunton, H. et al. (2019) HNF4A and GATA6 loss reveals therapeutically actionable subtypes in pancreatic cancer. Cell Press Sneak Peek, (doi: 10.2139/ssrn.3430714)

Reader, C. S. et al. (2019) The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy. Journal of Pathology, 249(3), pp. 332-342. (doi: 10.1002/path.5320) (PMID:31259422) (PMCID:PMC6852434)

Halbrook, C. J. et al. (2019) Macrophage-released pyrimidines inhibit gemcitabine therapy in pancreatic cancer. Cell Metabolism, 29(6), 1390-1399.e6. (doi: 10.1016/j.cmet.2019.02.001) (PMID:30827862) (PMCID:PMC6602533)

Collisson, Eric A., Bailey, Peter ORCID: https://orcid.org/0000-0002-0857-2041, Chang, David K. ORCID: https://orcid.org/0000-0002-4821-3078 and Biankin, Andrew V. ORCID: https://orcid.org/0000-0002-0362-5597 (2019) Molecular subtypes of pancreatic cancer. Nature Reviews Gastroenterology and Hepatology, 16, pp. 207-220. (doi: 10.1038/s41575-019-0109-y) (PMID:30718832)

Dreyer, S. B. et al. (2019) Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profiling. Chinese Clinical Oncology, 8(2), 16. (doi: 10.21037/cco.2019.04.06) (PMID:31070037)

"VSports" 2018

Chou, A. et al. (2018) Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer. Gut, 67(12), pp. 2142-2155. (doi: 10.1136/gutjnl-2017-315144) (PMID:29080858) (PMCID:PMC6241608)

Pinho, A. V. et al. (2018) ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling. Nature Communications, 9, 5083. (doi: 10.1038/s41467-018-07497-z) (PMID:30504844) (PMCID:PMC6269509)

Veenstra, V.L. et al. (2018) ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy. Oncogenesis, 7, 87. (doi: 10.1038/s41389-018-0096-9) (PMID:30442938) (PMCID:PMC6237826)

Candido, J. B. et al. (2018) CSF1R+ macrophages sustain pancreatic tumor growth through T cell suppression and maintenance of key gene programs that define the squamous subtype. Cell Reports, 23(5), pp. 1448-1460. (doi: 10.1016/j.celrep.2018.03.131) (PMID:29719257) (PMCID:PMC5946718)

"V体育安卓版" Sheahan, Anjali V., Biankin, Andrew V. ORCID: https://orcid.org/0000-0002-0362-5597, Parish, Christopher R. and Khachigian, Levon M. (VSports) (2018) Targeted therapies in the management of locally advanced and metastatic pancreatic cancer: a systematic review. Oncotarget, 9(30), pp. 21613-21627. (doi: 10.18632/oncotarget.25085) (PMID:29765563) (PMCID:PMC5940404)

Chin, Venessa, Nagrial, Adnan, Sjoquist, Katrin, O'Connor, Chelsie A., Chantrill, Lorraine, Biankin, Andrew V. ORCID: https://orcid.org/0000-0002-0362-5597, Scholten, Rob J.P.M. and Yip, Desmond (2018) Chemotherapy and radiotherapy for advanced pancreatic cancer. Cochrane Database of Systematic Reviews, 2018(3), CD011044. (doi: 10.1002/14651858.cd011044.pub2) (PMID:29557103) (PMCID:PMC6494171)

Grant, R. C. et al. (2018) Exome-wide association study of pancreatic cancer risk. Gastroenterology, 154(3), 719-722.e3. (doi: 10.1053/j.gastro.2017.10.015) (PMID:29074453) (PMCID:PMC5811358)

Dreyer, S.B., Jamieson, N.B. ORCID: https://orcid.org/0000-0002-9552-4725, VSports注册入口 - Upstill-Goddard, R., Bailey, P.J. ORCID: https://orcid.org/0000-0002-0857-2041, McKay, C.J. (V体育官网), Australian Pancreatic Cancer Genome Initiative, Biankin, A.V. ORCID: https://orcid.org/0000-0002-0362-5597 and Chang, D.K. ORCID: https://orcid.org/0000-0002-4821-3078 (2018) Defining the molecular pathology of pancreatic body and tail adenocarcinom. British Journal of Surgery, 105(2), e183-e191. (doi: 10.1002/bjs.10772) (PMID:29341146) (PMCID:PMC5817249)

Shroff, R. T. et al. (2018) Rucaparib monotherapy in patients with pancreatic cancer and a known deleterious BRCA mutation. JCO Precision Oncology, 2(1), (doi: 10.1200/po.17.00316) (PMID:30051098) (PMCID:PMC6057747)

"VSports注册入口" 2017

Cooke, S. L. et al. (2017) The driver mutational landscape of ovarian squamous cell carcinomas arising in mature cystic teratoma. Clinical Cancer Research, 23(24), pp. 7633-7640. (doi: 10.1158/1078-0432.CCR-17-1789) (PMID:28954785)

Balachandran, V. P. et al. (2017) Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer. Nature, 551, pp. 512-516. (doi: 10.1038/nature24462) (PMID:29132146) (PMCID:PMC6145146)

Scarpa, A. et al. (2017) Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours. Nature, 550(7677), p. 548. (doi: 10.1038/nature24026) (PMID:28953865)

Raphael, B. J. et al. (2017) Integrated genomic characterization of pancreatic ductal adenocarcinoma. Cancer Cell, 32(2), 185-203.e13. (doi: 10.1016/j.ccell.2017.07.007) (PMID:28810144) (PMCID:PMC5964983)

Harris, N.L.E. et al. (2017) SerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer. Oncogene, 36(30), pp. 4288-4298. (doi: 10.1038/onc.2017.63) (PMID:28346421) (PMCID:PMC5537606)

Feigin, M. E. et al. (2017) Recurrent noncoding regulatory mutations in pancreatic ductal adenocarcinoma. Nature Genetics, 49(6), pp. 825-833. (doi: 10.1038/ng.3861) (PMID:28481342) (PMCID:PMC5659388)

Johns, A. L. et al. (2017) Lost in translation: returning germline genetic results in genome-scale cancer research. Genome Medicine, 9, 41. (doi: 10.1186/s13073-017-0430-4) (PMID:28454591) (PMCID:PMC5408494)

Jung, L.A. et al. (2017) OmoMYC blunts promoter invasion by oncogenic MYC to inhibit gene expression characteristic of MYC-dependent tumors. Oncogene, 36(14), pp. 1911-1924. (doi: 10.1038/onc.2016.354) (PMID:27748763)

Vennin, C. et al. (2017) Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis. Science Translational Medicine, 9(384), eaai8504. (doi: 10.1126/scitranslmed.aai8504) (PMID:28381539) (PMCID:PMC5777504)

Dreyer, Stephan B., "V体育2025版" Chang, David K. ORCID: https://orcid.org/0000-0002-4821-3078, "VSports手机版" Bailey, Peter ORCID: https://orcid.org/0000-0002-0857-2041 and Biankin, Andrew V. ORCID: https://orcid.org/0000-0002-0362-5597 (2017) Pancreatic cancer genomes: implications for clinical management and therapeutic development. Clinical Cancer Research, 23(7), pp. 1638-1646. (doi: 10.1158/1078-0432.CCR-16-2411) (PMID:28373362)

Pishvaian, Michael J., Biankin, Andrew V. (V体育ios版) ORCID: https://orcid.org/0000-0002-0362-5597, Bailey, Peter ORCID: https://orcid.org/0000-0002-0857-2041, Chang, David K. ORCID: https://orcid.org/0000-0002-4821-3078, Laheru, Daniel (VSports最新版本), Wolfgang, Christopher L. and Brody, Jonathan R. (2017) BRCA2 secondary mutation-mediated resistance to platinum and PARP inhibitor-based therapy in pancreatic cancer. British Journal of Cancer, 116, pp. 1021-1026. (doi: 10.1038/bjc.2017.40) (PMID:28291774)

Scarpa, A. et al. (2017) Whole-genome landscape of pancreatic neuroendocrine tumours. Nature, 543(7643), pp. 65-71. (doi: 10.1038/nature21063) (PMID:28199314)

Biankin, Andrew V. ORCID: https://orcid.org/0000-0002-0362-5597 (2017) The road to precision oncology. Nature Genetics, 49(3), pp. 320-321. (doi: 10.1038/ng.3796) (PMID:28232728)

Vallejo, A. et al. (2017) An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer. Nature Communications, 8, 14294. (doi: 10.1038/ncomms14294) (PMID:28220783) (PMCID:PMC5321758)

Hardie, R.-A. et al. (2017) Mitochondrial mutations and metabolic adaptation in pancreatic cancer. Cancer and Metabolism, 5, 2. (doi: 10.1186/s40170-017-0164-1) (PMID:28163917) (PMCID:PMC5282905)

Byrne, A. T. et al. (2017) Interrogating open issues in cancer precision medicine with patient-derived xenografts. Nature Reviews Cancer, 17, pp. 254-268. (doi: 10.1038/nrc.2016.140) (PMID:28104906)

Humphris, J. L. et al. (2017) Hypermutation in pancreatic cancer. Gastroenterology, 152(1), 68-74.e2. (doi: 10.1053/j.gastro.2016.09.060) (PMID:27856273)

Martinelli, P. et al. (2017) GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer. Gut, 66, pp. 1665-1676. (doi: 10.1136/gutjnl-2015-311256) (PMID:27325420) (PMCID:PMC5070637)

2016

Sharbeen, George, Youkhana, Janet, Mawson, Amanda, McCarroll, Joshua, Nunez, Andrea, Biankin, Andrew ORCID: https://orcid.org/0000-0002-0362-5597, Johns, Amber, Goldstein, David and Phillips, Phoebe (2016) MutY-Homolog (MYH) inhibition reduces pancreatic cancer cell growth and increases chemosensitivity. Oncotarget, 8(6), pp. 9216-9229. (doi: 10.18632/oncotarget.13985) (PMID:27999205)

Roy, N. et al. (2016) PDX1 dynamically regulates pancreatic ductal adenocarcinoma initiation and maintenance. Genes and Development, 30(24), pp. 2669-2683. (doi: 10.1101/gad.291021.116) (PMID:28087712)

Sharbeen, G., McCarroll, J., Liu, J., Youkhana, J., Limbri, L.F., Biankin, A.V. ORCID: https://orcid.org/0000-0002-0362-5597, Johns, A., Kavallaris, M., Goldstein, D. and Phillips, P.A. (2016) Delineating the role of βIV-Tubulins in pancreatic cancer: βIVb-tubulin inhibition sensitizes pancreatic cancer cells to vinca alkaloids. Neoplasia, 18(12), pp. 753-764. (doi: 10.1016/j.neo.2016.10.011) (PMID:27889644) (PMCID:PMC5126129)

Bailey, P. et al. (2016) Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma. Scientific Reports, 6, 35848. (doi: 10.1038/srep35848) (PMID:27762323) (PMCID:PMC5071896)

Humphrey, E. S. et al. (2016) Resolution of novel pancreatic ductal adenocarcinoma subtypes by global phosphotyrosine profiling. Molecular and Cellular Proteomics, 15(8), pp. 2671-2685. (doi: 10.1074/mcp.M116.058313) (PMID:27259358) (PMCID:PMC4974343)

Swanton, C. et al. (2016) Consensus on precision medicine for metastatic cancers: a report from the MAP conference. Annals of Oncology, 27(8), pp. 1443-1448. (doi: 10.1093/annonc/mdw192) (PMID:27143638)

Steele, C. W. et al. (2016) CXCR2 inhibition profoundly suppresses metastases and augments immunotherapy in pancreatic ductal adenocarcinoma. Cancer Cell, 29(6), pp. 832-845. (doi: 10.1016/j.ccell.2016.04.014) (PMID:27265504) (PMCID:PMC4912354)

Kleeff, J. et al. (2016) Pancreatic cancer. Nature Reviews Disease Primers, 2, 16022. (doi: 10.1038/nrdp.2016.22) (PMID:27158978)

Bailey, P. et al. (2016) Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), pp. 47-52. (doi: 10.1038/nature16965) (PMID:26909576)

Humphris, Jeremy L. and Biankin, Andrew V. ORCID: https://orcid.org/0000-0002-0362-5597 (2016) Diagnosis and management of hereditary pancreatic cancer. In: Pichert, Gabriella (V体育平台登录) and Jacobs, Chris (eds.) Rare Hereditary Cancers: Diagnosis and Management. Series: Recent results in cancer research (205). Springer International Publishing: Cham, pp. 61-83. ISBN 9783319299969 (doi: 10.1007/978-3-319-29998-3_5)

2015

Basturk, O. et al. (2015) A revised classification system and recommendations from the Baltimore Consensus Meeting for neoplastic precursor lesions in the pancreas. American Journal of Surgical Pathology, 39(12), pp. 1730-1741. (doi: 10.1097/PAS.0000000000000533) (PMID:26559377) (PMCID:PMC4646710)

Nagrial, Adnan M., Chin, Venessa T., Sjoquist, Katrin M., Pajic, Marina, Horvath, Lisa G., Biankin, Andrew ORCID: https://orcid.org/0000-0002-0362-5597 and "V体育ios版" Yip, Desmond (2015) Second-line treatment in inoperable pancreatic adenocarcinoma: A systematic review and synthesis of all clinical trials. Critical Reviews in Oncology/Hematology, 96(3), pp. 483-497. (doi: 10.1016/j.critrevonc.2015.07.007) (PMID:26481952)

Jamieson, Nigel B. ORCID: https://orcid.org/0000-0002-9552-4725, Chang, David K. ORCID: https://orcid.org/0000-0002-4821-3078 and Biankin, Andrew V. ORCID: https://orcid.org/0000-0002-0362-5597 (2015) Cancer genetics and implications for clinical management. Surgical Clinics of North America, 95(5), pp. 919-934. (doi: 10.1016/j.suc.2015.05.003) (PMID:26315514)

Graham, J., Jamieson, N.B. (V体育2025版) ORCID: https://orcid.org/0000-0002-9552-4725, Rulach, R., Grimmond, S.M., Chang, D.K. ORCID: https://orcid.org/0000-0002-4821-3078 and V体育安卓版 - Biankin, A.V. ORCID: https://orcid.org/0000-0002-0362-5597 (2015) Pancreatic cancer genomics: where can the science take us? Clinical Genetics, 88(3), pp. 213-219. (doi: 10.1111/cge.12536) (PMID:25388820)

Chantrill, L.A. et al. (2015) Precision medicine for advanced pancreas cancer: the individualized molecular pancreatic cancer therapy (IMPaCT) trial. Clinical Cancer Research, 21(9), pp. 2029-2037. (doi: 10.1158/1078-0432.CCR-15-0426) (PMID:25896973)

Susanto, J. M. et al. (2015) The epigenetic agents suberoylanilide hydroxamic acid and 5‑AZA‑2' deoxycytidine decrease cell proliferation, induce cell death and delay the growth of MiaPaCa2 pancreatic cancer cells in vivo. International Journal of Oncology, 46(5), pp. 2223-30. (doi: 10.3892/ijo.2015.2894) (PMID:25695794)

Carlino, M.S. et al. (2015) New RAS-mutant pancreatic adenocarcinoma with combined BRAF and MEK inhibition for metastatic melanoma. Journal of Clinical Oncology, 33(11), e52-e56. (doi: 10.1200/JCO.2013.51.5783) (PMID:24821886)

V体育安卓版 - Humphris, Jeremy, VSports手机版 - Chang, David K. ORCID: https://orcid.org/0000-0002-4821-3078 and Biankin, Andrew V. (VSports最新版本) ORCID: https://orcid.org/0000-0002-0362-5597 (2015) Inherited susceptibility to pancreatic cancer in the era of next-generation sequencing. Gastroenterology, 148(3), pp. 496-498. (doi: 10.1053/j.gastro.2015.01.009) (PMID:25613311)

Waddell, N. et al. (2015) Whole genomes redefine the mutational landscape of pancreatic cancer. Nature, 518(7540), pp. 495-501. (doi: 10.1038/nature14169) (PMID:25719666) (PMCID:PMC4523082)

McCarroll, J. A. et al. (2015) βIII-tubulin: a novel mediator of chemoresistance and metastases in pancreatic cancer. Oncotarget, 6(4), pp. 2235-2249. (PMID:25544769) (PMCID:PMC4385848)

Biankin, Andrew V ORCID: https://orcid.org/0000-0002-0362-5597, Piantadosi, Steven and Hollingsworth, Simon J. (2015) Patient-centric trials for therapeutic development in precision oncology. Nature, 526, pp. 361-370. (doi: 10.1038/nature15819) (PMID:26469047)

Chin, Venessa, Nagrial, Adnan, Chou, Angela (VSports手机版), "VSports" Biankin, Andrew V. ORCID: https://orcid.org/0000-0002-0362-5597, Gill, Anthony, Timpson, Paul and Pajic, Marina (V体育安卓版) (2015) Rho-associated kinase signalling and the cancer microenvironment: novel biological implications and therapeutic opportunities. Expert Reviews in Molecular Medicine, 17, e17. (doi: 10.1017/erm.2015.17) (PMID:26507949)

Miller, B. W. et al. (2015) Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy. EMBO Molecular Medicine, 7, pp. 1063-1076. (doi: 10.15252/emmm.201404827) (PMID:26077591) (PMCID:PMC4551344)

"V体育安卓版" Tactacan, C.M., V体育安卓版 - Phua, Y.W., Liu, L., Zhang, L., Humphrey, E.S., "V体育官网" Cowley, M., Pinese, M., Biankin, A.V. ORCID: https://orcid.org/0000-0002-0362-5597 and Daly, R.J. (2015) The pseudokinase SgK223 promotes invasion of pancreatic ductal epithelial cells through JAK1/Stat3 signaling. Molecular Cancer, 14, 139. (doi: 10.1186/s12943-015-0412-3) (PMID:26215634) (PMCID:PMC4517651)

2014 (VSports app下载)

Humphris, J. L. et al. (2014) Clinical and pathologic features of familial pancreatic cancer. Cancer, 120(23), pp. 3669-3675. (doi: 10.1002/cncr.28863) (PMID:25313458)

Hudson, Andrew M., Yates, Tim (VSports app下载), "VSports" Li, Yaoyong, Trotter, Eleanor W., Fawdar, Shameem, V体育2025版 - Chapman, Phil, Lorigan, Paul, Biankin, Andrew ORCID: https://orcid.org/0000-0002-0362-5597, "VSports注册入口" Miller, Crispin ORCID: https://orcid.org/0000-0003-4341-1283 and Brognard, John (2014) Discrepancies in cancer genomic sequencing highlight opportunities for driver mutation discovery. Cancer Research, 74(22), pp. 6390-6396. (doi: 10.1158/0008-5472.CAN-14-1020) (PMID:25256751)

Grimont, A. et al. (2014) SOX9 regulates ERBB signalling in pancreatic cancer development. Gut, 64(11), pp. 1790-1799. (doi: 10.1136/gutjnl-2014-307075) (PMID:25336113)

Nones, K. et al. (2014) Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. International Journal of Cancer, 135(5), pp. 1110-1118. (doi: 10.1002/ijc.28765) (PMID:24500968)

Morran, D. C. et al. (2014) Targeting mTOR dependency in pancreatic cancer. Gut, 63(9), pp. 1481-1489. (doi: 10.1136/gutjnl-2013-306202) (PMID:24717934) (PMCID:PMC4145424)

Quek, K. et al. (2014) A workflow to increase verification rate of chromosomal structural rearrangements using high-throughput next-generation sequencing. BioTechniques, 57(1), pp. 31-38. (doi: 10.2144/000114189)

Sjoquist, K. M. et al. (2014) Personalising pancreas cancer treatment: when tissue is the issue. World Journal of Gastroenterology, 20(24), pp. 7849-7863. (doi: 10.3748/wjg.v20.i24.7849) (PMID:24976722) (PMCID:PMC4069313)

Al-Ejeh, F. et al. (2014) Gemcitabine and CHK1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreatic ductal adenocarcinoma. Clinical Cancer Research, 20(12), pp. 3187-3197. (doi: 10.1158/1078-0432.CCR-14-0048) (PMID:24838526)

Johns, A. L. et al. (2014) Returning individual research results for genome sequences of pancreatic cancer. Genome Medicine, 6(5), 42. (doi: 10.1186/gm558) (PMID:24963353) (PMCID:PMC4067993)

Jamieson, Nigel Balfour (V体育官网) ORCID: https://orcid.org/0000-0002-9552-4725, Chang, David K (VSports手机版) ORCID: https://orcid.org/0000-0002-4821-3078, Grimmond, Sean M (V体育官网) and Biankin, Andrew V ORCID: https://orcid.org/0000-0002-0362-5597 (2014) Can we move towards personalised pancreatic cancer therapy? Expert Review of Gastroenterology and Hepatology, 8(4), pp. 335-338. (doi: 10.1586/17474124.2014.893820) (PMID:24702631)

Weissmueller, S. et al. (2014) Mutant p53 drives pancreatic cancer metastasis through cell-autonomous PDGF receptor β signaling. Cell, 157(2), pp. 382-394. (doi: 10.1016/j.cell.2014.01.066) (PMID:24725405) (PMCID:PMC4001090)

VSports app下载 - Chang, David K ORCID: https://orcid.org/0000-0002-4821-3078, Grimmond, Sean M (V体育ios版) and Biankin, Andrew V ORCID: https://orcid.org/0000-0002-0362-5597 (2014) Pancreatic cancer genomics. Current Opinion in Genetics and Development, 24, pp. 74-81. (doi: 10.1016/j.gde.2013.12.001) (PMID:24480245)

Nagrial, A.M. et al. (2014) Adjuvant chemotherapy in elderly patients with pancreatic cancer. British Journal of Cancer, 110(2), pp. 313-319. (doi: 10.1038/bjc.2013.722) (PMID:24263063) (PMCID:PMC3899761)

Chang, David K. ORCID: https://orcid.org/0000-0002-4821-3078, Grimmond, Sean M., "V体育平台登录" Evans, Thomas R.J. ORCID: https://orcid.org/0000-0002-4175-914X and Biankin, Andrew V. ORCID: https://orcid.org/0000-0002-0362-5597 (2014) Mining the genomes of exceptional responders. Nature Reviews Cancer, 14(5), pp. 291-292. (doi: 10.1038/nrc3723) (PMID:25688402)

Chang, David K. ORCID: https://orcid.org/0000-0002-4821-3078, V体育平台登录 - Jamieson, Nigel B. ORCID: https://orcid.org/0000-0002-9552-4725, Grimmond, Sean M. and Biankin, Andrew V. ORCID: https://orcid.org/0000-0002-0362-5597 (2014) Stratified medicine for pancreatic cancer. In: Padmanabhan, Sandosh (ed.) Handbook of Pharmacogenomics and Stratified Medicine. Elsevier, pp. 807-814. ISBN 9780123868824 (doi: 10.1016/B978-0-12-386882-4.00034-7)

Hidalgo, M. et al. (2014) Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research. Cancer Discovery, 4(9), pp. 998-1013. (doi: 10.1158/2159-8290.CD-14-0001)

Jamieson, Nigel B. ORCID: https://orcid.org/0000-0002-9552-4725, Grimmond, Sean M., Biankin, Andrew V. ORCID: https://orcid.org/0000-0002-0362-5597 and Chang, David K. ORCID: https://orcid.org/0000-0002-4821-3078 (2014) Pancreatic cancer: Challenges for therapeutic development. In: Scarlett, Christopher J. and Vuong, Quan V. (eds.) Plant Bioactive Compounds for Pancreatic Cancer Prevention and Treatment. Nova Science, pp. 1-28. ISBN 9781634633246

2013 (VSports)

Kassahn, K. S. et al. (2013) Somatic point mutation calling in low cellularity tumors. PLoS ONE, 8(11), e74380. (doi: 10.1371/journal.pone.0074380) (PMID:24250782) (PMCID:PMC3826759)

Chang, David K. (VSports app下载) ORCID: https://orcid.org/0000-0002-4821-3078, Jamieson, Nigel B. ORCID: https://orcid.org/0000-0002-9552-4725, Scarpa, Aldo, McKay, Colin J. and Biankin, Andrew V. ORCID: https://orcid.org/0000-0002-0362-5597 (2013) Reply to G.F. Arroyo. Journal of Clinical Oncology, 31(30), pp. 3843-3844. (doi: 10.1200/JCO.2013.51.3176) (PMID:24043730)

Cowley, M.J., Chang, D.K. ORCID: https://orcid.org/0000-0002-4821-3078, Pajic, M. (V体育平台登录), "V体育ios版" Johns, A.L., Waddell, N., Grimmond, S.M. and "V体育官网入口" Biankin, A.V. ORCID: https://orcid.org/0000-0002-0362-5597 (2013) Understanding pancreatic cancer genomes. Journal of Hepato-Biliary-Pancreatic Sciences, 20(6), pp. 549-556. (doi: 10.1007/s00534-013-0610-6) (PMID:23660961)

Cao, Y. et al. (2013) Neuropilin-2 promotes extravasation and metastasis by interacting with endothelial 5 integrin. Cancer Research, 73(14), pp. 4579-4590. (doi: 10.1158/0008-5472.CAN-13-0529) (PMID:23689123) (PMCID:PMC3774599)

Chang, D.K. et al. (2013) Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. Journal of Clinical Oncology, 31(10), pp. 1348-1356. (doi: 10.1200/JCO.2012.46.8868) (PMID:23439753)

Alexandrov, L.B. et al. (2013) Signatures of mutational processes in human cancer. Nature, 500(7463), pp. 415-421. (doi: 10.1038/nature12477)

Chou, A. et al. (2013) Clinical and molecular characterization of HER2 amplified-pancreatic cancer. Genome Medicine, 5(8), p. 78. (doi: 10.1186/gm482) (PMID:24004612) (PMCID:PMC3978667)

Liu, P.Y. et al. (2013) The histone deacetylase SIRT2 stabilizes Myc oncoproteins. Cell Death and Differentiation, 20(3), pp. 503-514. (doi: 10.1038/cdd.2012.147) (PMID:23175188) (PMCID:PMC3569991)

2012 (VSports app下载)

Biankin, A.V. et al. (2012) Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature, 491(7424), pp. 399-405. (doi: 10.1038/nature11547) (PMID:23103869) (PMCID:PMC3530898)

Tactacan, C. M. et al. (2012) RON is not a prognostic marker for resectable pancreatic cancer. BMC Cancer, 12(1), 395. (doi: 10.1186/1471-2407-12-395) (PMID:22958871) (PMCID:PMC3532183)

Pérez-Mancera, P.A. et al. (2012) The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. Nature, 486(7402), pp. 266-270. (doi: 10.1038/nature11114)

Humphris, J.L. et al. (2012) The prognostic and predictive value of serum CA19.9 in pancreatic cancer. Annals of Oncology, 23(7), pp. 1713-1722. (doi: 10.1093/annonc/mdr561) (PMID:22241899) (PMCID:PMC3387824)

Mann, K. M. et al. (2012) Inaugural article: Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma. Proceedings of the National Academy of Sciences of the United States of America, 109(16), pp. 5934-5941. (doi: 10.1073/pnas.1202490109) (PMID:2242144) (PMCID:PMC1663246)

2011

Colvin, E.K. et al. (2011) Retinoid signaling in pancreatic cancer, injury and regeneration. PLoS ONE, 6(12), e29075. (doi: 10.1371/journal.pone.0029075) (PMID:22220202) (PMCID:PMC3248409)

Chang, David K. ORCID: https://orcid.org/0000-0002-4821-3078, Grimmond, Sean M. (V体育官网入口) and Biankin, Andrew V. ORCID: https://orcid.org/0000-0002-0362-5597 (2011) Molecular diagnostics in pancreatic cancer. In: Friess, Helmut (VSports注册入口) and Hüser, Norbert (eds.) Advances in Pancreatic Cancer Treatment. Future Medicine Ltd., pp. 20-35. ISBN 9781780840703 (doi: 10.2217/EBO.11.330)

Scarlett, C. J. et al. (2011) Recruitment and activation of pancreatic stellate cells from the bone marrow in pancreatic cancer: a model of tumor-host interaction. PLoS ONE, 6(10), e26088. (doi: 10.1371/journal.pone.0026088) (PMID:22022519) (PMCID:PMC3193536)

Pajic, Marina, Scarlett, Christopher J., Chang, David K. (VSports手机版) ORCID: https://orcid.org/0000-0002-4821-3078, Sutherland, Robert L. (VSports) and Biankin, Andrew V. ORCID: https://orcid.org/0000-0002-0362-5597 (2011) Preclinical strategies to define predictive biomarkers for therapeutically relevant cancer subtypes. Human Genetics, 130(1), pp. 93-101. (doi: 10.1007/s00439-011-0990-0) (PMID:21516344)

Nguyen, N. Q. et al. (2011) Clinical and immunohistochemical features of 34 solid pseudopapillary tumors of the pancreas. Journal of Gastroenterology and Hepatology, 26(2), pp. 267-274. (doi: 10.1111/j.1440-1746.2010.06466.x) (PMID:21261715)

Chong, J.J.H. et al. (2011) Adult cardiac-resident msc-like stem cells with a proepicardial origin. Cell Stem Cell, 9(6), pp. 527-540. (doi: 10.1016/j.stem.2011.10.002)

VSports最新版本 - 2010

Marshall, G.M. et al. (2010) Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects. Oncogene, 29(44), pp. 5957-5968. (doi: 10.1038/onc.2010.332) (PMID:20697349)

2009

Leong, Rupert W.L., Chang, David ORCID: https://orcid.org/0000-0002-4821-3078, Merrett, Neil D. and Biankin, Andrew V. ORCID: https://orcid.org/0000-0002-0362-5597 (2009) Taking optical biopsies with confocal endomicroscopy. Journal of Gastroenterology and Hepatology, 24(11), pp. 1701-1703. (doi: 10.1111/j.1440-1746.2009.06011.x) (PMID:20136953)

Chang, D.K. et al. (2009) Margin clearance and outcome in resected pancreatic cancer. Journal of Clinical Oncology, 27(17), pp. 2855-2862. (doi: 10.1200/JCO.2008.20.5104) (PMID:19398572)

Nguyen, Nam Q. (V体育平台登录), V体育安卓版 - Biankin, Andrew V. ORCID: https://orcid.org/0000-0002-0362-5597, "VSports手机版" Leong, Rupert W. L., Chang, David K. ORCID: https://orcid.org/0000-0002-4821-3078, Cosman, Peter H., Delaney, Peter, Kench, James G. and Merrett, Neil D. (2009) Real time intraoperative confocal laser microscopy-guided surgery. Annals of Surgery, 249(5), pp. 735-737. (doi: 10.1097/SLA.0b013e3181a38f11) (PMID:19387332)

Gill, A. J. et al. (2009) Synoptic reporting improves histopathological assessment of pancreatic resection specimens. Pathology, 41(2), pp. 161-167. (doi: 10.1080/00313020802337329) (PMID:19320058)

Biankin, A.V. et al. (2009) Expression of S100A2 calcium-binding protein predicts response to pancreatectomy for pancreatic cancer. Gastroenterology, 137(2), 558-568.e11. (doi: 10.1053/j.gastro.2009.04.009) (PMID:19376121)

Chang, David K. ORCID: https://orcid.org/0000-0002-4821-3078, V体育安卓版 - Nguyen, Nam Q., Merrett, Neil D., Dixson, Hugh., Leong, Rupert W.L. and Biankin, Andrew V. ORCID: https://orcid.org/0000-0002-0362-5597 (2009) Role of endoscopic ultrasound in pancreatic cancer. Expert Review of Gastroenterology and Hepatology, 3(3), pp. 293-303. (doi: 10.1586/egh.09.18) (PMID:19485810)

"V体育安卓版" 2008

Colvin, Emily K., Chang, David K. ORCID: https://orcid.org/0000-0002-4821-3078, Merrett, Neil D., "VSports手机版" Kench, James G. and Biankin, Andrew V. ORCID: https://orcid.org/0000-0002-0362-5597 (2008) Individualizing therapy for pancreatic cancer. Journal of Gastroenterology and Hepatology, 23(12), pp. 1779-1782. (doi: 10.1111/j.1440-1746.2008.05683.x) (PMID:19120869)

Das, Amitabha, Chang, David ORCID: https://orcid.org/0000-0002-4821-3078, Biankin, Andrew V. ORCID: https://orcid.org/0000-0002-0362-5597 and VSports app下载 - Merrett, Neil D. (2008) Pancreatitis following human papillomavirus vaccination. Medical Journal of Australia, 189(3), p. 178. (doi: 10.5694/j.1326-5377.2008.tb01960.x) (PMID:18673112)

Chang, David K. ORCID: https://orcid.org/0000-0002-4821-3078, Merrett, Neil D. (V体育ios版) and "V体育官网" Biankin, Andrew V. ORCID: https://orcid.org/0000-0002-0362-5597 (2008) Improving outcomes for operable pancreatic cancer: Is access to safer surgery the problem? Journal of Gastroenterology and Hepatology, 23(7pt1), pp. 1036-1045. (doi: 10.1111/j.1440-1746.2008.05471.x) (PMID:18707598)

Murphy, N.C. et al. (2008) Expression of LMO4 and outcome in pancreatic ductal adenocarcinoma. British Journal of Cancer, 98(3), pp. 537-541. (doi: 10.1038/sj.bjc.6604177)

Leong, R.W.L., "V体育官网" Nguyen, N.Q., Meredith, C.G. (V体育2025版), Al–Sohaily, S., Kukic, D., Delaney, P.M., Murr, E.R. (V体育平台登录), Yong, J., Merrett, N.D. and Biankin, A.V. ORCID: https://orcid.org/0000-0002-0362-5597 (2008) In vivo confocal endomicroscopy in the diagnosis and evaluation of celiac disease. Gastroenterology, 135(6), pp. 1870-1876. (doi: 10.1053/j.gastro.2008.08.054)